SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001068238-21-000088
Filing Date
2021-03-26
Accepted
2021-03-26 08:10:07
Documents
1
Group Members
RIVENDELL INVESTMENTS 2017-9 LLC

Document Format Files

Seq Description Document Type Size
1 PETER THIEL SCHEDULE 13G thiel_sch13g.htm SC 13G 55656
  Complete submission text file 0001068238-21-000088.txt   57337
Mailing Address 9200 SUNSET BOULEVARD SUITE 1110 WEST HOLLYWOOD CA 90069
Business Address 9200 SUNSET BOULEVARD SUITE 1110 WEST HOLLYWOOD CA 90069 323-990-2000
THIEL PETER (Filed by) CIK: 0001211060 (see all company filings)

IRS No.: 000000000
Type: SC 13G

Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Subject) CIK: 0001534248 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86953 | Film No.: 21774772
SIC: 2834 Pharmaceutical Preparations